Determining the Role of Prophylactic Tranexamic Acid in Reducing Blood Loss during and after Lower Segment Caesarean Section | Chapter 20 | New Frontiers in Medicine and Medical Research Vol. 6

 This is a prospective randomised control trial that looks at the role of intravenous tranexamic acid in reducing blood loss during caesarean delivery. From August 2018 to August 2020, the study was conducted at the department of Obstetrics & Gynaecology (inpatient only) of Central Hospital, South Eastern Railways, Kolkata. Our goals were to compare the amount of blood loss during caesarean section between patients who received intravenous tranexamic acid and those who received placebo (Normal Saline), as well as the amount of blood loss 2 hours after caesarean section between patients who received intravenous tranexamic acid and those who received placebo. The patients were divided into two groups based on their gender. The study found that using tranexamic acid as a preventative measure lowers blood loss during and after a lower segment caesarean surgery.

Author (S) Details

Neha Agarwal
DNB Gynaecology and Obstetrics Department of Gynaecology and Obstetrics Central Hospital, South Eastern Railways Garden Reach, Kolkata - 700043, India.

Anupam Lahiri
DNB General Surgery Department of General Surgery Central Hospital, South Eastern Railways Garden Reach, Kolkata – 700043, India.

View Book :- https://stm.bookpi.org/NFMMR-V6/article/view/2778

Research on Dendritic Cell Based Vaccine for Human Tuberculosis | Chapter 3 | Highlights on Medicine and Medical Science Vol. 8

 The modern vaccine concept claims that it can be used for both preventive and therapeutic objectives. Furthermore, vaccines are currently used to prevent both infectious and non-infectious disorders. There are several types of vaccines that are commonly used in medicine. Cell-based vaccinations are one of them. Vaccinations based on DCs function as both vaccines and vaccine immunoadjuvant biologics. Currently, there are experimental DC-based vaccines for viral, bacterial, fungal, and protozoal infections. The current chapter was devoted to a DC-based human TB vaccination.

Author (s) Details

Dr. Ibrahim M. S. A. W. Shnawa
Hilla University College, Raringia, Babylon, Iraq and Department of Biotechnology, College of Biotechnology University of Qasim, Qasim, Babylon, Iraq.

View Book :- https://stm.bookpi.org/HMMS-V8/article/view/2163